1. Home
  2. SLGL vs MVO Comparison

SLGL vs MVO Comparison

Compare SLGL & MVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • MVO
  • Stock Information
  • Founded
  • SLGL 1997
  • MVO 2006
  • Country
  • SLGL Israel
  • MVO United States
  • Employees
  • SLGL N/A
  • MVO N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • MVO Oil & Gas Production
  • Sector
  • SLGL Health Care
  • MVO Energy
  • Exchange
  • SLGL Nasdaq
  • MVO Nasdaq
  • Market Cap
  • SLGL 69.1M
  • MVO 68.9M
  • IPO Year
  • SLGL 2018
  • MVO N/A
  • Fundamental
  • Price
  • SLGL $23.98
  • MVO $6.00
  • Analyst Decision
  • SLGL
  • MVO
  • Analyst Count
  • SLGL 0
  • MVO 0
  • Target Price
  • SLGL N/A
  • MVO N/A
  • AVG Volume (30 Days)
  • SLGL 33.1K
  • MVO 55.1K
  • Earning Date
  • SLGL 11-14-2025
  • MVO 01-01-0001
  • Dividend Yield
  • SLGL N/A
  • MVO 17.46%
  • EPS Growth
  • SLGL N/A
  • MVO N/A
  • EPS
  • SLGL N/A
  • MVO 1.46
  • Revenue
  • SLGL $23,931,000.00
  • MVO N/A
  • Revenue This Year
  • SLGL N/A
  • MVO N/A
  • Revenue Next Year
  • SLGL $31.17
  • MVO N/A
  • P/E Ratio
  • SLGL N/A
  • MVO $7.29
  • Revenue Growth
  • SLGL 264.86
  • MVO N/A
  • 52 Week Low
  • SLGL $4.01
  • MVO $8.85
  • 52 Week High
  • SLGL $30.00
  • MVO $13.95
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 58.56
  • MVO 55.76
  • Support Level
  • SLGL $23.13
  • MVO $5.87
  • Resistance Level
  • SLGL $24.85
  • MVO $6.05
  • Average True Range (ATR)
  • SLGL 2.36
  • MVO 0.12
  • MACD
  • SLGL -0.43
  • MVO 0.01
  • Stochastic Oscillator
  • SLGL 39.19
  • MVO 72.37

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About MVO MV Oil Trust Units of Beneficial Interests

MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.

Share on Social Networks: